top of page

Spotlight: Nov 21-Jan 22

Updated: Feb 17, 2022

Words by Jade Williams

GOLD takes a look back at some of the top news stories from the pharmaceutical industry over the last few months, ranging from the latest in COVID-19 developments and recent drug approvals to standout mergers and acquisitions

23 November

Nykode Therapeutics and Regeneron partner to develop vaccines for cancer and infectious diseases

24 November

The European Commission grants breast cancer drug Trodelvy marketing authorisation

26 November

UKHSA confirms COVID-19 vaccines are safe for pregnant women and offer high levels of protection

2 December

Researchers discover possible trigger for the rare blood clots caused by AstraZeneca’s vaccine

8 December

Gedeon Richter UK acquires marketing authorisation for first transdermal contraceptive in UK

13 December

Pfizer’s atopic dermatitis treatment Cibinqo granted approval from the European Commission

22 December

Oxford and AstraZeneca announce plan to produce updated vaccine targeting Omicron variant

5 January

Pfizer and BioNTech to collaborate on developing first mRNA-based shingles vaccine

6 January

Merck acquires biopharmaceutical CDMO Exelead to strengthen its mRNA offerings

11 January

The European Commission grants approval of cystic fibrosis treatment for six- to 11-year-olds

18 January

NHS launches HEART study – a world-first pilot in genetic testing for common diseases like breast cancer

19 January

AstraZeneca’s Imfinzi drug reduces risk of death in patients with biliary tract cancer

This news round up features in GOLD 20 – read the full issue here.

bottom of page